Operating Income (Loss) in USD of Fresh Tracks Therapeutics, Inc. from Q2 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Fresh Tracks Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q4 2023.
  • Fresh Tracks Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$1.65M, a 64% increase year-over-year.
  • Fresh Tracks Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$6.36M, a 70.5% increase year-over-year.
  • Fresh Tracks Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$6.36M, a 70.5% increase from 2022.
  • Fresh Tracks Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$21.5M, a 46.5% increase from 2021.
  • Fresh Tracks Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$40.2M, a 91.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Fresh Tracks Therapeutics, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$6.36M -$1.65M +$2.94M +64% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$9.3M $2M +$8.07M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$17.4M -$2.36M -$906K -62.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 -$16.5M -$4.34M +$5.07M +53.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 -$21.5M -$4.59M +$1.71M +27.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$23.2M -$6.08M +$7.28M +54.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$30.5M -$1.46M +$10.1M +87.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$40.6M -$9.41M -$405K -4.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$40.2M -$6.31M +$1.1M +14.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$41.3M -$13.4M -$9.01M -207% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$32.3M -$11.6M -$6.45M -126% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-09-01
Q1 2021 -$25.9M -$9M -$4.9M -120% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$21M -$7.4M +$3.44M +31.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$24.4M -$4.35M +$1.71M +28.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$26.1M -$5.13M -$2.15M -72.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$24M -$4.1M +$494K +10.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$24.5M -$10.8M -$7.24M -201% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-18
Q3 2019 -$17.2M -$6.06M -$3.76M -163% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$13.5M -$2.98M +$336K +10.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$13.8M -$4.59M -$5.36M -701% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$8.45M -$3.6M +$280K +7.22% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 -$8.73M -$2.3M +$882K +27.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-18
Q2 2018 -$9.61M -$3.32M +$96K +2.81% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-18
Q1 2018 -$9.71M $764K +$3.68M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-18
Q4 2017 -$13.4M -$3.88M -$1.11M -39.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$12.3M -$3.18M -$610K -23.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 -$11.7M -$3.41M -$2.09M -158% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$9.58M -$2.91M -$403K -16.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$9.18M -$2.78M -$353K -14.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$8.82M -$2.57M -$2.24M -672% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-24
Q2 2016 -$6.59M -$1.32M +$1.47M +52.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$8.06M -$2.51M +$1.35M +34.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$9.4M -$2.42M +$2.26M +48.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 -$11.7M -$333K +$4.06M +92.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$15.7M -$2.79M +$1.27M +31.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$17M -$3.86M -$374K -10.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$16.6M -$4.68M -$2.46M -111% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$14.2M -$4.4M +$5.58M +56% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 -$19.8M -$4.07M +$5.78M +58.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 -$25.5M -$3.48M +$5.82M +62.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$31.4M -$2.22M +$5.35M +70.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 -$36.7M -$9.98M -$2.2M -28.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-03
Q2 2013 -$34.5M -$9.84M -$1.91M -24% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 -$32.6M -$9.31M -$9.17M -6548% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 -$23.4M -$7.58M -$530K -7.52% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 -$22.9M -$7.78M -$24.2M -147% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $1.27M -$7.94M +$514K +6.08% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $755K -$140K +$8.58M +98.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$7.82M -$7.05M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-14
Q3 2011 $16.4M +$23.2M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 -$8.45M +$54K +0.64% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 -$8.72M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q3 2010 -$6.81M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$8.51M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-03

Fresh Tracks Therapeutics, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$6.36M +$15.2M +70.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 -$21.5M +$18.7M +46.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 -$40.2M -$19.3M -91.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$21M +$3.49M +14.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$24.5M -$16M -190% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 -$8.45M +$4.94M +36.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-18
2017 -$13.4M -$4.21M -45.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-01
2016 -$9.18M +$227K +2.41% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$9.4M +$7.22M +43.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 -$16.6M +$14.7M +47% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 -$31.4M -$7.92M -33.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 -$23.4M -$15.6M -200% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-26
2011 -$7.82M +$23.4M +74.9% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-14
2010 -$31.2M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.